Key Insights

Highlights

Success Rate

96% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.7%

1 terminated out of 37 trials

Success Rate

96.0%

+9.5% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

13%

3 of 24 completed with results

Key Signals

3 with results96% success

Data Visualizations

Phase Distribution

27Total
Not Applicable (16)
P 1 (3)
P 2 (7)
P 3 (1)

Trial Status

Completed24
Recruiting6
Unknown4
Active Not Recruiting1
Withdrawn1
Terminated1

Trial Success Rate

96.0%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT06860516RecruitingPrimary

HLA Demographics Study in Adults With Type 1 Diabetes

NCT06850441Not ApplicableCompletedPrimary

Effects of Education on Stigma and Quality of Life in Individuals With Type 1 Diabetes

NCT02081326Phase 2Active Not Recruiting

Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes

NCT07011147Not ApplicableRecruiting

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT06688331Phase 2Recruiting

Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody

NCT02970357Not ApplicableCompletedPrimary

Evaluation of the Impact of a Therapeutic Education Program for Children With Type 1 Diabetes

NCT06729242Not ApplicableRecruitingPrimary

Influence of Menstrual Cycle Phases on the Glycemic Control of Aerobic or HIIT Exercise in Adult Women With Type 1 Diabetes

NCT06945744Not ApplicableCompletedPrimary

Carbohydrate Counting and Bolus Calculator Mobile Application Improves Time in Range in Adults With Type 1 Diabetes

NCT06919029RecruitingPrimary

Effect of Advanced Hybrid Closed Loop System, MiniMed 780G in Newly Diagnosed Children and Adolescents With Type 1 Diabetes on Glycemic Control and Patient Reported Outcomes Compared to Standard Insulin Therapy Historical Data (AHCL in New Onset T1D Children Study)

NCT06849622Not ApplicableRecruiting

Auto-antibody Dosage From Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease

NCT00306098Phase 2CompletedPrimary

Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression

NCT06147583Not ApplicableUnknownPrimary

Assessing Detection Algorithms for Insulin Pump Malfunctions in Type 1 Diabetes

NCT05708820Not ApplicableUnknownPrimary

Online Education Programme for People With Type 1 Diabetes and Suboptimal Metabolic Control

NCT04591925Not ApplicableTerminatedPrimary

SteadiSet™ Pilot Study (SteP Study)

NCT00789308Phase 2CompletedPrimary

Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation

NCT02521675Not ApplicableCompletedPrimary

Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity in Real Life Conditions

NCT02835014CompletedPrimary

Mental Health Screenings in Adolescents With Type I Diabetes

NCT02556554Not ApplicableCompletedPrimary

Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy

NCT01781975Phase 2CompletedPrimary

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

NCT01919788Not ApplicableCompletedPrimary

Intracellular Counter-regulatory Mechanisms Following Low Blood Glucose

Scroll to load more

Research Network

Activity Timeline